Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
112,318,617
-
Total 13F shares
-
111,825,275
-
Share change
-
+10,966,691
-
Total reported value
-
$3,615,108,333
-
Put/Call ratio
-
366%
-
Price per share
-
$32.45
-
Number of holders
-
237
-
Value change
-
+$350,007,462
-
Number of buys
-
126
-
Number of sells
-
104
Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q1 2023
As of 31 Mar 2023,
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by
237 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
111,825,275 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Rock Springs Capital Management LP, Granahan Investment Management, LLC, Invesco Ltd., ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, and DIMENSIONAL FUND ADVISORS LP.
This page lists
237
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.